Neovasc Inc. Net Cash/Marketcap

Net Cash/Marketcap of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Cash/Marketcap growth rates and interactive chart.


Highlights and Quick Summary

Current Net Cash/Marketcap of Neovasc Inc. is $-1.33 (as of December 31, 2021)
  • Net Cash/Marketcap for the quarter ending March 31, 2022 was $-1.09 (a -18.1% decrease compared to previous quarter)
  • Year-over-year quarterly Net Cash/Marketcap increased by 25.89%
  • Annual Net Cash/Marketcap for 2021 was $-1.33 (a 624.54% increase from previous year)
  • Annual Net Cash/Marketcap for 2020 was $-0.184 (a -169.1% decrease from previous year)
  • Annual Net Cash/Marketcap for 2019 was $0.266 (a -57.98% decrease from previous year)
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Cash/Marketcap of Neovasc Inc.

Most recent Net Cash/Marketcapof NVCN including historical data for past 10 years.

Interactive Chart of Net Cash/Marketcap of Neovasc Inc.

Neovasc Inc. Net Cash/Marketcap for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.0
2021 $0.0 $0.0 $0.0 $0.0 $0.0
2020 $0.0 $0.0 $0.0 $0.0 $0.0
2019 $0.0 $0.0 $0.0 $0.0 $0.0
2018 $0.0 $0.0 $0.0 $0.0 $0.0
2017 $0.0 $0.0 $0.0 $0.0 $0.0
2016 $0.0 $0.0 $0.0 $0.0 $0.0
2015 $0.0 $0.0 $0.0 $0.0 $0.0
2014 $0.0 $0.0 $0.0 $0.0 $0.0
2013 $0.0 $0.0 $0.0 $0.0 $0.0
2012 $0.0 $0.0 $0.0 $0.0 $0.0
2011 $0.0 $0.0

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.